| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.989 | 0 | 0.989 | Lanosterol 14 alpha demethylase inhibitor | 0.988 0 DBMET00374 | ||
| 0.953 | 0.002 | 0.954 | Hedgehog signaling inhibitor | 0.954 0.002 DBMET00374 | DBMET00374 | |
| 0.696 | 0.009 | 0.696 | Angiogenesis inhibitor | 0.566 0.02 DBMET00374 | ||
| 0.549 | 0.002 | 0.571 | Cell wall synthesis inhibitor | 0.571 0.002 DBMET00374 | DBMET00374 | |
| 0.458 | 0.011 | 0.467 | P-glycoprotein inhibitor | 0.467 0.01 DBMET00374 | DBMET00374 | |
| 0.393 | 0.029 | 0.393 | Hypoglycemic | 0.376 0.032 DBMET00374 | ||
| 0.398 | 0.078 | 0.453 | Antibacterial | 0.453 0.056 DBMET00374 | DBMET00374 | |
| 0.321 | 0.035 | 0.321 | Anticonvulsant | 0.148 0.132 DBMET00374 | ||
| 0.357 | 0.084 | 0.357 | Antiobesity | 0.292 0.121 DBMET00374 | ||
| 0.296 | 0.03 | 0.296 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.218 0.059 DBMET00374 | ||
| 0.264 | 0.004 | 0.264 | Smo receptor antagonist | 0.182 0.005 DBMET00374 | ||
| 0.264 | 0.009 | 0.264 | Alpha 2c adrenoreceptor antagonist | 0.141 0.037 DBMET00374 | ||
| 0.238 | 0.002 | 0.238 | CC chemokine 4 receptor antagonist | 0.137 0.003 DBMET00374 | ||
| 0.341 | 0.129 | 0.353 | Cyclophilin D inhibitor | 0.353 0.12 DBMET00374 | DBMET00374 | |
| 0.176 | 0.002 | 0.176 | Heme oxygenase inhibitor | 0.163 0.002 DBMET00374 | ||
| 0.198 | 0.028 | 0.198 | Alpha adrenoreceptor antagonist | 0.172 0.032 DBMET00374 | ||
| 0.163 | 0.012 | 0.163 | Aromatase inhibitor | 0.12 0.018 DBMET00374 | ||
| 0.224 | 0.08 | 0.224 | Hypolipemic | 0.216 0.084 DBMET00374 | ||
| 0.161 | 0.034 | 0.161 | Alpha 2b adrenoreceptor antagonist | |||
| 0.129 | 0.005 | 0.129 | CXC chemokine 1 receptor antagonist | 0.088 0.007 DBMET00374 | ||
| 0.183 | 0.06 | 0.183 | Heat shock protein 90 alpha antagonist | 0.146 0.091 DBMET00374 | ||
| 0.117 | 0.004 | 0.117 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.068 0.005 DBMET00374 | ||
| 0.23 | 0.119 | 0.23 | Hypoxia-inducible factor 1 alpha inhibitor | 0.219 0.131 DBMET00374 | ||
| 0.107 | 0.003 | 0.107 | Parathyroid hormone antagonist | 0.104 0.003 DBMET00374 | ||
| 0.138 | 0.04 | 0.177 | Antiadrenergic | 0.177 0.029 DBMET00374 | DBMET00374 | |
| 0.13 | 0.033 | 0.13 | Alpha 2 adrenoreceptor antagonist | 0.075 0.074 DBMET00374 | ||
| 0.135 | 0.039 | 0.175 | Adrenaline antagonist | 0.175 0.028 DBMET00374 | DBMET00374 | |
| 0.093 | 0.036 | 0.093 | 5 Hydroxytryptamine agonist | |||
| 0.065 | 0.02 | 0.065 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.039 | 0.007 | 0.039 | CYP24 inhibitor | 0.035 0.008 DBMET00374 | ||
| 0.07 | 0.041 | 0.07 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.06 | 0.033 | 0.06 | 5 Hydroxytryptamine 1 agonist | |||
| 0.027 | 0.005 | 0.027 | Microsomal triglyceride transfer protein inhibitor | |||
| 0.029 | 0.024 | 0.029 | Squalene synthetase inhibitor | 0.028 0.025 DBMET00374 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |